ABSTRACT
Height has an extremely polygenic pattern of inheritance. Genome-wide association studies (GWAS) have revealed hundreds of common variants that are associated with human height at genome-wide levels of significance. However, only a small fraction of phenotypic variation can be explained by the aggregate of these common variants. In a large study of African-American men and women (n = 14,419), we genotyped and analyzed 966,578 autosomal SNPs across the entire genome using a linear mixed model variance components approach implemented in the program GCTA (Yang et al Nat Genet 2010), and estimated an additive heritability of 44.7% (se: 3.7%) for this phenotype in a sample of evidently unrelated individuals. While this estimated value is similar to that given by Yang et al in their analyses, we remain concerned about two related issues: (1) whether in the complete absence of hidden relatedness, variance components methods have adequate power to estimate heritability when a very large number of SNPs are used in the analysis; and (2) whether estimation of heritability may be biased, in real studies, by low levels of residual hidden relatedness. We addressed the first question in a semi-analytic fashion by directly simulating the distribution of the score statistic for a test of zero heritability with and without low levels of relatedness. The second question was addressed by a very careful comparison of the behavior of estimated heritability for both observed (self-reported) height and simulated phenotypes compared to imputation R2 as a function of the number of SNPs used in the analysis. These simulations help to address the important question about whether today's GWAS SNPs will remain useful for imputing causal variants that are discovered using very large sample sizes in future studies of height, or whether the causal variants themselves will need to be genotyped de novo in order to build a prediction model that ultimately captures a large fraction of the variability of height, and by implication other complex phenotypes. Our overall conclusions are that when study sizes are quite large (5,000 or so) the additive heritability estimate for height is not apparently biased upwards using the linear mixed model; however there is evidence in our simulation that a very large number of causal variants (many thousands) each with very small effect on phenotypic variance will need to be discovered to fill the gap between the heritability explained by known versus unknown causal variants. We conclude that today's GWAS data will remain useful in the future for causal variant prediction, but that finding the causal variants that need to be predicted may be extremely laborious.
Subject(s)
Black People/genetics , Body Height/genetics , Polymorphism, Single Nucleotide/genetics , Female , Genome-Wide Association Study/methods , Genotype , Humans , Linear Models , Male , Models, Genetic , Phenotype , Regression AnalysisABSTRACT
Estrogen receptor (ER)-negative breast cancer shows a higher incidence in women of African ancestry compared to women of European ancestry. In search of common risk alleles for ER-negative breast cancer, we combined genome-wide association study (GWAS) data from women of African ancestry (1,004 ER-negative cases and 2,745 controls) and European ancestry (1,718 ER-negative cases and 3,670 controls), with replication testing conducted in an additional 2,292 ER-negative cases and 16,901 controls of European ancestry. We identified a common risk variant for ER-negative breast cancer at the TERT-CLPTM1L locus on chromosome 5p15 (rs10069690: per-allele odds ratio (OR) = 1.18 per allele, P = 1.0 × 10(-10)). The variant was also significantly associated with triple-negative (ER-negative, progesterone receptor (PR)-negative and human epidermal growth factor-2 (HER2)-negative) breast cancer (OR = 1.25, P = 1.1 × 10(-9)), particularly in younger women (<50 years of age) (OR = 1.48, P = 1.9 × 10(-9)). Our results identify a genetic locus associated with estrogen receptor negative breast cancer subtypes in multiple populations.
Subject(s)
Breast Neoplasms/genetics , Genetic Loci , Membrane Proteins/genetics , Neoplasm Proteins/genetics , Receptors, Estrogen/metabolism , Telomerase/genetics , Black or African American , Aged , Breast Neoplasms/ethnology , Breast Neoplasms/metabolism , Case-Control Studies , Female , Genetic Predisposition to Disease , Genome-Wide Association Study , Genotype , Humans , Middle Aged , Polymorphism, Single Nucleotide , Receptors, Estrogen/genetics , White PeopleABSTRACT
Palpation of movement is a common clinical tool for assessment of movement in patients with musculoskeletal symptoms. The purpose of this study was to measure the accuracy of palpation of shoulder girdle translation during the medial rotation test (MRT) of the shoulder. The translation of the gleno-humeral and scapulo-thoracic joints was measured using both three-dimensional ultrasound and palpation in order to determine the accuracy of translation tracking during the MRT of the shoulder. Two movements of 11 normal subjects (mean age 24 (SD=4), range 19-47 years) were measured. The agreement between measures was good for scapulo-thoracic translation (r=0.83). Gleno-humeral translation was systematically under estimated (p=0.03) although moderate correlation was found (r=0.65). These results indicate that translation of the measured joints can be tracked by palpation and further tests of the efficacy of palpation tracking during musculoskeletal assessment may be warranted.
Subject(s)
Humerus/physiology , Range of Motion, Articular/physiology , Rotator Cuff/physiology , Scapula/physiology , Shoulder Joint/physiology , Adult , Biomechanical Phenomena , Female , Humans , Humerus/diagnostic imaging , Imaging, Three-Dimensional/methods , Linear Models , Male , Middle Aged , Palpation/methods , Rotator Cuff/diagnostic imaging , Scapula/diagnostic imaging , Sensitivity and Specificity , Shoulder Joint/diagnostic imaging , Tomography, X-Ray Computed/methods , Ultrasonography , United KingdomSubject(s)
Retirement , Social Security , Adolescent , Adult , Aged , Child , Female , Humans , Male , Middle Aged , Social Security/legislation & jurisprudence , United StatesABSTRACT
August 14, 1980, marks the 45th anniversary of the signing of the Social Security Act. Across the country, we have held town meetings where people have discussed the past 45 years of social security and assessed the implications for the future. Now I would like to take the opportunity to convey my personal views of the past and future of social security, both as Commissioner and as an individual who has watched the program evolve over the years.